Abstract
Background: Osteopetrosis is a heterogeneous group of diseases that are characterized by increased bone density due to abnormalities in osteoclast differentiation or function, which result in a lack of bone resorption.
Case reports: Two patients with osteopetrosis onset since the first months of life, with facial dysmorphia, blindness, deafness, hepatosplenomegaly, hypotonia, neurodevelopmental retardation and bicytopenia. Bone radiographs showed osteosclerosis. They were assessed by different specialists prior to definitive diagnosis. Genetic analysis determined mutations in the TCIRG1 gene. Patient 1 had a homozygous mutation for p.Ile720Alafs*14 identified, which hasn’t been previously reported. Patient 2 had a compound heterozygous mutation: the first one, p.Phe459Leufs*79, and the second one, p.Gly159Argfs*68, none of which has been previously reported as far as we know.
Conclusion: The only therapeutic option for patients with osteopetrosis is hematopoietic stem cell transplantation (HSCT), which should be carried out in the course of the first 3 months of life, before neurological damage occurs. Although osteopetrosis diagnosis is relatively simple, it is delayed owing to the lack of clinical suspicion.
References
Essabar L, Meskini T, Ettair S, Erreimi N, Mouane N. Malignant infantile osteopetrosis: case report with review of literature. Pan Afr Med J. 2014;17:63. DOI: 10.11604/pamj.2014.17.63.3759
Usta M, Gulec SG, Karaman S, Erdem E, Emral H, Urganci N. A case report of malignant infantile osteopetrosis. Iran J Pediatr. 2012;22(3):421-424.
Del-Fattore A, Cappariello A, Teti A. Genetics, pathogenesis and complications of osteopetrosis. Bone. 2008;42(1):19-29. DOI: 10.1016/j.bone.2007.08.029
Coudert AE, De-Vernejoul MC, Muraca M, Del-Fattore A. Osteopetrosis and its relevance for the discovery of new functions associated with the skeleton. Intern J Endocrinol. 2015;2015:372156. DOI: 10.1155/2015/372156
Anderson SL, Jalas C, Fedick A, Reid KF, Carpenter TO, Chirnomas D, et al. A founder mutation in the TCIRG1 gene causes osteopetrosis in the Ashkenazi Jewish population. Clin Genet. 2015;88(1):74-79. DOI: 10.1111/cge
Frattini A, Orchard PJ, Sobacchi C, Giliani S, Abinun M, Mattsson JP, et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat Genet. 2000;25(3):343-346. DOI: 10.1038/77131
Guyton A. Tratado de fisiología médica. España: Elsevier; 2011.
Sobacchi C, Schulz A, Coxon FP, Villa A, Helfrich MH. Osteopetrosis: genetics, treatment and new insights into osteoclast function. Nat Rev Endocrinol. 2013;9(9):522-536. DOI: 10.1038/nrendo.2013.137
Toranzo-Fernandez JM, Noyola-Frias MA, Hernandez-Duarte SP. Infantile osteopetrosis: a case report with osteomyelitis of the maxilla. J Clin Pediatr Dent. 2002;27(1):77-80.
Ba ID, Ba A, Thiongane A, Ba M, Fattah M, Faye PM, et al. Malignant infantile osteopetrosis revealed by choanal atresia: a case report. Arch Pediatr. 2016;23(5):514-518. DOI: 10.1016/j.arcped.2016.02.006
Guerrini MM, Sobacchi C, Cassani B, Abinun M, Kilic SS, Pangrazio A, et al. Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations. Am J Hum Genet. 2008;83(1):64-76. DOI: 10.1016/j.ajhg.2008.06.015
Balemans W, Van-Wesenbeeck L, Van-Hul W. A clinical and molecular overview of the human osteopetroses. Calcif Tissue Int. 2005;77(5):263-274. DOI: 10.1007/s00223-005-0027-6
Pangrazio A, Caldana ME, Sobacchi C, Panaroni C, Susani L, Mihci E, et al. Characterization of a novel Alu-Alu recombination-mediated genomic deletion in the TCIRG1 gene in five osteopetrotic patients. Journal of bone and mineral research. J Bone Miner Res. 2009;24(1):162-167. DOI: 10.1359/jbmr.080818
Palagano E, Susani L, Menale C, Ramenghi U, Berger M, Uva P, et al. Synonymous mutations add a layer of complexity in the diagnosis of human osteopetrosis. J Bone Miner Res. 2017;32(1):99-105. DOI: 10.1002/jbmr.2929
Askmyr MK, Fasth A, Richter J. Towards a better understanding and new therapeutics of osteopetrosis. Br J Haematol. 2008;140(6):597-609. DOI: 10.1111/j.1365-2141.2008.06983.x
Mazzolari E, Forino C, Razza A, Porta F, Villa A, Notarangelo LD. A single-center experience in 20 patients with infantile malignant osteopetrosis. Am J Hematol. 2009;84(8):473-479. DOI: 10.1002/ajh.21447
Steward CG. Neurological aspects of osteopetrosis. Neuropathol Appl Neurobiol. 2003;29(2):87-97. DOI: 10.1046/j.1365-2990.2003.00474.x
Shamriz O, Shaag A, Yaacov B, NaserEddin A, Weintraub M, Elpeleg O, et al. The use of whole exome sequencing for the diagnosis of autosomal recessive malignant infantile osteopetrosis. Clin Genet. 2017;92(1):80-85. DOI: 10.1111/cge.12804
Llano OG, Perez JC, Rodriguez OC, Guerra CM, Aguirre HG, Garza JL, et al. Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico. Pediatric Hematol Oncol. 2008;25(1):39-47. DOI: 10.1080/08880010701773621
Ruiz-Argüelles GJ, Gómez-Almaguer D, Tarin-Arzaga LD, Morales-Toquero A, Cantu-Rodriguez OG, Manzano C. Second allogeneic peripheral blood stem cell transplants with reduced-intensity conditioning. Rev Invest Clin. 2006;58(1):34-38.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2018 Revista Alergia México